|
|||||
|
|
Phase I/II study of 3TC (lamivudine) in HIV-positive, asymptomatic or mild AIDS-related complex patients: sustained reduction in viral markers. The Lamivudine European HIV Working Group |
|
| Authors: | D Ingrand J Weber CA Boucher C Loveday C Robert A Hill N Cammack |
| Affiliation: | Department of Medical Virology, Pitié-Salpétrière Hospital, Paris, France. |
| Abstract: | |
| Keywords: | |
| 本文献已被 PubMed 等数据库收录！ | |